Pioneering Clinical Research Innovation Across the World

CEO @ bioaccess® | Fast-Tracking First-in-Human Trials Worldwide | 40% Faster Approvals, 30% Lower Costs | MedTech & Biopharma Partner

Julio G. Martinez-Clark stands at the forefront of clinical research transformation as President of IAOCR/GCSA Americas and CEO of bioaccess®, where he bridges global quality standards with the America’s growing Medtech ecosystem. With over two decades of cross-industry leadership spanning healthcare, telecommunications, and venture capital, Martinez-Clark has become the trusted partner for 100+ Medtech companies seeking accelerated regulatory approvals and cost-effective clinical trials worldwide. His unique fusion of technical expertise from Johns Hopkins Hospital infrastructure projects, regulatory acumen honed through UNESCO-aligned accreditations, and operational mastery of the different world's clinical trial landscapes positions him as the definitive authority on risk-mitigated medical device innovation in emerging markets.

Strategic Leadership in Global Clinical Research Standards  

Presidential Stewardship at IAOCR/GCSA Americas  

As President of IAOCR/GCSA Americas since October 2024, Martinez-Clark leads the regional implementation of the International Accredited Organization for Clinical Researchers (IAOCR) and Good Clinical Practice (GCP) standards. 

bioaccess®: Redefining Medtech Clinical Trials  

Founding bioaccess® in 2010, Martinez-Clark built the first CRO specializing in First-in-Human (FIH) and Early Feasibility Studies (EFS) for medical devices across Latin America, Eastern Europe, and Australia. The Miami-based firm achieves:  

• 70% cost reduction compared to U.S. trials through optimized site selection algorithms  

• 58-day average approval timelines for CE Mark studies vs. 194 days in EU markets  

• 93% patient retention rates via culturally adapted recruitment protocols

Notable successes include facilitating the world’s first transcatheter mitral valve replacement trial in Colombia and a groundbreaking study in Panama, highlighting Harvard University's breakthroughs toward achieving stable, high-density, and clinically viable brain-computer interfaces. This technology promises to help millions of patients suffering from neurological disorders.

Multidisciplinary Expertise Driving Healthcare Innovation  

Regulatory Architecture & Public Policy  

Martinez-Clark’s tenure as Board Chairman of AVANZAR (2024) contributed to helping catalyze Colombia as a regional clinical trial leader. 

His advisory role to the Cámara de Comercio de Barranquilla is transforming the city into Colombia’s first clinical trial district, poised to attract $25M in clinical trial investments by 2030.  

Technology Commercialization & Cross-Border Collaboration  

Martinez-Clark’s technical pedigree spans:  

• Healthcare Infrastructure: Led Johns Hopkins teams implementing Trinidad & Tobago’s first Vendor Neutral Archive (VNA) medical imaging network  

• Telecom Innovation: Designed Alcatel-Lucent’s multi-dwelling broadband solutions deployed across 9 Latin American countries  

• Corporate Transformation: Architected Amavita Heart and Vascular Health™’s digital presence, and expanded the company's healthcare portfolio to include supplements, hormone replacement therapy, and an international patient program  

This multidisciplinary approach informs his podcast, “LATAM Medtech Leaders,” which has 127 episodes and features insights from CEOs and startup founders on navigating regional regulatory landscapes.  

Academic Foundations & Thought Leadership  

Educational Credentials  

• M.B.A.: Western New England University (Springfield, MA) - Operational Strategy  

• B.S. Electronics Engineering: Saint Thomas University (Bogotá) - Telecom and Networking Systems Design

Industry-Shaping Publications  

As Contributing Writer for Med Device Online since 2018, Martinez-Clark’s 23 articles have become essential reading for Medtech executives, including:  

• “LATAM's Regulatory Framework For Medtech Early Feasibility Studies” (2022)  

• “Latin America's Landscape For Medtech Clinical Trials” (2022)  

• “Latin America: A Compelling Region To Conduct Your Clinical Trials” (2022) 

Vision for the Future of Global Healthcare  

Residing in Miami while maintaining operational hubs in Orlando and Bogotá, Martinez-Clark continues advocating for:  

• Standardization: Implementing IAOCR’s Global Competency Framework across 50+ sites in the Americas by 2026  

• Clinical Trial Infrastructure: Developing the capacity for Latin American, Eastern European, and Australian sites to conduct early feasibility clinical trials with advanced medical technologies

• Knowledge Transfer: Closing the innovation gap between the Western world and developing countries.

Through bioaccess® and IAOCR/GCSA Americas, Julio G. Martinez-Clark remains committed to his vision: “A world where geographical boundaries don’t limit access to medical innovation, but diverse populations globally contribute to and benefit from healthcare advancements”.